Astrana Health PE Ratio 2016-2026 | ASTH
Current and historical p/e ratio for Astrana Health (ASTH) from 2016 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Astrana Health PE ratio as of June 15, 2026 is 31.40.
| Astrana Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-06-16 | 38.38 | 62.92 | |
| 2026-03-31 | 24.52 | $0.61 | 40.20 |
| 2025-12-31 | 24.81 | $0.46 | 53.93 |
| 2025-09-30 | 28.35 | $0.20 | 141.75 |
| 2025-06-30 | 24.88 | $0.52 | 47.85 |
| 2025-03-31 | 31.01 | $0.73 | 42.48 |
| 2024-12-31 | 31.53 | $0.90 | 35.03 |
| 2024-09-30 | 57.94 | $1.30 | 44.57 |
| 2024-06-30 | 40.56 | $1.44 | 28.17 |
| 2024-03-31 | 41.99 | $1.32 | 31.81 |
| 2023-12-31 | 38.30 | $1.29 | 29.69 |
| 2023-09-30 | 30.85 | $0.96 | 32.14 |
| 2023-06-30 | 31.60 | $0.99 | 31.92 |
| 2023-03-31 | 36.47 | $0.97 | 37.60 |
| 2022-12-31 | 29.59 | $0.99 | 29.89 |
| 2022-09-30 | 39.00 | $1.26 | 30.95 |
| 2022-06-30 | 38.59 | $1.50 | 25.73 |
| 2022-03-31 | 48.47 | $1.52 | 31.89 |
| 2021-12-31 | 73.48 | $1.52 | 48.34 |
| 2021-09-30 | 91.05 | $1.58 | 57.63 |
| 2021-06-30 | 62.81 | $1.29 | 48.69 |
| 2021-03-31 | 27.09 | $1.20 | 22.58 |
| 2020-12-31 | 18.27 | $1.01 | 18.09 |
| 2020-09-30 | 17.94 | $0.95 | 18.88 |
| 2020-06-30 | 16.50 | $0.60 | 27.50 |
| 2020-03-31 | 12.92 | $0.50 | 25.84 |
| 2019-12-31 | 18.41 | $0.39 | 47.21 |
| 2019-09-30 | 17.62 | $0.11 | 160.18 |
| 2019-06-30 | 16.71 | $0.25 | 66.84 |
| 2019-03-31 | 18.32 | $0.23 | 79.65 |
| 2018-12-31 | 19.85 | $0.29 | 68.45 |
| 2018-09-30 | 22.07 | $0.85 | 25.96 |
| 2018-06-30 | 25.86 | $0.81 | 31.93 |
| 2018-03-31 | 15.95 | $0.81 | 19.69 |
| 2017-12-31 | 24.00 | $0.90 | 26.67 |
| 2017-09-30 | 9.75 | $0.42 | 23.21 |
| 2017-06-30 | 10.00 | $0.22 | 45.45 |
| 2017-03-31 | 9.00 | $0.15 | 60.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.536B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |